<DOC>
	<DOCNO>NCT02169817</DOCNO>
	<brief_summary>Primary Objective : To demonstrate effectiveness treatment Bacillus clausii probiotic strain ( Enterogermina ) combination oral rehydration therapy ( ORT ) period 5 day , duration acute community-acquired diarrhea Latin American child . Secondary Objectives : To evaluate clinical safety Enterogermina acute diarrhea child demonstrate effectiveness stool frequency , stool consistency , number vomit episode . To evaluate parent 's overall global assessment . To evaluate safety effectiveness Enterogermina norovirus acute gastroenteritis ( AGE ) .</brief_summary>
	<brief_title>Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children</brief_title>
	<detailed_description>The maximum duration study participation patient 10 day .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Gastroenteritis</mesh_term>
	<criteria>Inclusion criterion : Infants child acute communityacquired diarrhea ( â‰¥3 liquid watery stool occur 24hour period ) : le 48 hour duration age 6 month 5 year age whose parent legal guardian give write informed consent clinical indication ORT per formula World Health Organization Exclusion criterion : Infants child : presence blood , pu , mucus stool severe dehydration untreatable vomit antibiotic indication treatment acute diarrhea ; hospitalization expect hospitalization next hour due poor clinical condition treatment antibiotic , probiotic , prebiotics within period 2 week enrolment ( use probiotic prebiotics dairy food yoghurt , cheese , milk prior study permit ) previous use ( within 48 hour ) kaolin , pectin , bismuth subsalicylate , racecadotril , loperamide , atropine anticholinergic agent indication ORT different one prescribed study chronic disease include chronic diarrhea immunodeficiency ( acquire congenital immunodeficiency ) infectious comorbid condition know hypersensitivity Bacillus clausii ( Enterogermina ) probiotic parent/legal guardian , opinion Investigator , unable complete patient diary bring child followup visit participation another clinical trial last 3 month prior start study . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>